0.50
+0(+0.00%)
Currency In USD
Address
Maxim 1
Motherwell, ML1 4WR
United Kingdom of Great Britain and Northern Ireland
Phone
44 14 1433 7557
Website
Sector
Healthcare
Industry
Biotechnology
Employees
41
First IPO Date
February 11, 2022
| Name | Title | Pay | Year Born |
| Mr. Bryan Leland Kobel | Chief Executive Officer & Director | 544,560 | 1979 |
| Mr. Martin Edward Thorp | Chief Financial Officer & Director | 410,521 | 1952 |
| Mr. Christopher Camarra | Executive Vice President of Communications | 0 | N/A |
| Dr. Lauren Bor Ph.D. | Head of Commercial Development Division | 0 | N/A |
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.